The effect of Condrosulf® (sodiumchondroitinsulfate) on total proteoglycan synthesis by human osteoarthritic and bovine juvenile articular chondrocytes -: an in vitro study

被引:1
作者
Bobacz, K [1 ]
Erlacher, L [1 ]
Graninger, WB [1 ]
机构
[1] Univ Vienna, Innere Med Klin 3, Klin Abt Rheumatol, A-1090 Vienna, Austria
关键词
Condrosulf((R)); sodiumchondroitinsulfate; osteoarthritis; chondrocytes; cartilage;
D O I
10.1046/j.1563-2571.2002.01039.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Sodiumchondroitinsulfate, Condrosulf(R), is used in osteoarthritis therapy and belongs to the group of symptomatic slow-acting drugs for osteoarthritis. The aim of this study was to investigate the effects of Condrosulf(R) on total proteoglycan synthesis and cell proliferation in human osteoarthritis and healthy juvenile bovine chondrocytes in vitro. Methods: Chondrocytes were grown as monolayers and stimulated for 7 (human cartilage), or 4, 8 and 12 days (bovine cartilage) with different concentrations of Condrosulf(R) (100 mug/ml, 500 mug/ml, 1000 mug/ml, 2500 mug/ml and 5000 mug/ml). Proteoglycan synthesis was measured by [S-35]Sulfate incorporation. The cell proliferation rate was determined using a [H-3]Thymidin assay. The expression of the cartilage markers aggrecan and collagen type II was assessed by Northern blot analysis. Results: We show that the incubation with Condrosulf(R) did not affect proteoglycan synthesis neither in osteoarthritis, nor in healthy chondrocytes under the present culture conditions. Cell proliferation rate was also not increased by Condrosulf(R) stimulation. The results of the Northern blot assays demonstrated a dose-dependent down regulation of aggrecan expression on mRNA level. Conclusions: These data indicate a lack of direct anabolic effects of Condrosulf(R) on the biosynthetic activity of cultured articular chondrocytes. The well known ease of clinical symptoms, such as pain or swelling under Condrosulf(R) medication may be interpreted by an interaction with pro-inflammatory cytokines.
引用
收藏
页码:20 / 25
页数:6
相关论文
共 13 条
[1]   Effects of chondroitin sulfate and interleukin-1β on human articular chondrocytes cultivated in clusters [J].
Bassleer, CT ;
Combal, JPA ;
Bougaret, S ;
Malaise, M .
OSTEOARTHRITIS AND CARTILAGE, 1998, 6 (03) :196-204
[2]   Efficacy and tolerability of chondroitin sulfate 1200 mg/day vs chondroitin sulfate 3 x 400 mg/day vs placebo [J].
Bourgeois, P ;
Chales, G ;
Dehais, J ;
Delcambre, B ;
Kuntz, JL ;
Rozenberg, S .
OSTEOARTHRITIS AND CARTILAGE, 1998, 6 :25-30
[3]   Efficacy and tolerability of oral chondroitin sulfate as a symptomatic slow-acting drug for osteoarthritis (SYSADOA) in the treatment of knee osteoarthritis [J].
Bucsi, L ;
Poór, G .
OSTEOARTHRITIS AND CARTILAGE, 1998, 6 :31-36
[4]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[5]   Osteoarthritis [J].
Creamer, P ;
Hochberg, MC .
LANCET, 1997, 350 (9076) :503-509
[6]   Cartilage-derived morphogenetic proteins and osteogenic protein-1 differentially regulate osteogenesis [J].
Erlacher, L ;
Mccartney, J ;
Piek, E ;
Ten Dijke, P ;
Yanagishita, M ;
Oppermann, H ;
Luyten, FP .
JOURNAL OF BONE AND MINERAL RESEARCH, 1998, 13 (03) :383-392
[7]   WEIGHT-LOSS REDUCES THE RISK FOR SYMPTOMATIC KNEE OSTEOARTHRITIS IN WOMEN - THE FRAMINGHAM-STUDY [J].
FELSON, DT ;
ZHANG, YQ ;
ANTHONY, JM ;
NAIMARK, A ;
ANDERSON, JJ .
ANNALS OF INTERNAL MEDICINE, 1992, 116 (07) :535-539
[8]   PROTEOGLYCANS OF ARTICULAR-CARTILAGE - CHANGES IN AGING AND IN JOINT DISEASE [J].
HARDINGHAM, T ;
BAYLISS, M .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 1990, 20 (03) :12-33
[9]   Anti-inflammatory activity of chondroitin sulfate [J].
Ronca, F ;
Palmieri, L ;
Panicucci, P ;
Ronca, G .
OSTEOARTHRITIS AND CARTILAGE, 1998, 6 :14-21
[10]  
TRELSTAD RL, 1997, TXB RHEUMATOLOGY, V1, P37